For the quarter ending 2026-03-31, CODX made $145,954 in revenue. -$9,140,038 in net income. Net profit margin of -6262.27%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| total revenue | 145,954 | 263,922 | 145,380 | 162,910 |
| Cost of revenue | 193,768 | 142,396 | 26,285 | 32,106 |
| Gross profit (loss) | -47,814 | 121,526 | 119,095 | 130,804 |
| Sales and marketing | 467,955 | 545,451 | 568,937 | 609,713 |
| General and administrative | 2,503,126 | 1,869,207 | 1,815,945 | 2,599,982 |
| Research and development | 5,934,071 | 5,099,086 | 4,480,678 | 4,687,459 |
| Depreciation and amortization | 255,445 | 267,566 | 267,383 | 291,414 |
| Impairment charges | - | 18,882,000 | - | - |
| Total operating expenses | 9,160,597 | 26,663,310 | 7,132,943 | 8,188,568 |
| Loss from operations | -9,208,411 | -26,541,784 | -7,013,848 | -8,057,764 |
| Realized gain on investments | - | 0 | 41,542 | 340,358 |
| Gain (loss) on disposition of assets | - | -74,915* | 4,000 | -9,004 |
| Interest income, net | 6,974 | 253,979 | 13,194 | 12,158 |
| Gain on remeasurement of acquisition contingencies | 75,280 | 118,417* | -42,345 | 10,222 |
| Gain on equity method investment in joint ventures | -13,361 | 24,862 | -55,959 | -13,760 |
| Total other income, net | 68,893 | 322,343 | -39,568 | 339,974 |
| Loss before income taxes | -9,139,518 | -26,219,441 | -7,053,416 | -7,717,790 |
| Income tax provision | 520 | -473,716 | -1,166,593 | 12,327 |
| Net loss | -9,140,038 | -25,745,725 | -5,886,823 | -7,730,117 |
| Change in net unrealized gains (losses) on marketable securities, net of tax | - | -94,888 | -39,180 | -196,585 |
| Total other comprehensive income (loss) | - | -94,888 | -39,180 | -196,585 |
| Comprehensive loss | -9,140,038 | -25,840,613 | -5,926,003 | -7,926,702 |
| Basic EPS | -4.06 | 0.264 | -0.16 | -0.23 |
| Diluted EPS | -4.06 | 0.264 | -0.16 | -0.23 |
| Basic Average Shares | 2,253,474 | -97,727,475 | 37,890,923 | 33,108,399 |
| Diluted Average Shares | 2,253,474 | -97,727,475 | 37,890,923 | 33,108,399 |
Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc. (CODX)